- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02098447
Pilot Study on Auricular Vagus Nerve Stimulation Effects in Chronic Diabetic Wounds
Evaluation of Electrical Auricular Vagal Nerve Stimulation Effects on Parameters of Wound Healing in Chronic Diabetic Wounds - Pilot Study
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Vienna, Austria, 1090
- University Clinic for Surgery, Department of Transplantation, Medical University Vienna
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- diabetes mellitus type 2
- ulcus cruris (plantar)
- min. 6 weeks of standard wound therapy without success
- intact big toe on wound side
Exclusion Criteria:
- participation in a clinical trial in the last 5 weeks
- confounding medical treatment, e.g. prostaglandin
- vascular diseases other than peripheral arterial occlusive disease
- diseases which may affect the autonomous nervous system or wound healing, except diabetic concomitant diseases (e.g., polyneuropathy, angiopathy)
- drug abuse
- active implanted devices
- pregnancy or nursing
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: auricular vagal nerve stimulation
Study participants (healthy and diabetics) are treated with auricular vagal nerve stimulation using four needle electrodes connected to an electrical stimulation device (PrimeStim). After an acclimatization phase the stimulation is turned on for 20 minutes followed by 20 minutes of paused stimulation, 20 minutes of stimulation, and another 10 minutes paused stimulation. This intervention is repeated on four consecutive days. Needle electrodes stay fixed over the whole study period. Two different stimulation schemes are tested, each being assessed twice in random order. Stimulation amplitudes are adjusted with respect to a distinct but comfortable sensation at the auricle. During the described protocol various biosignals are continuously recorded, including ECG, respiration, blood perfusion, oxygen saturation, transcutaneous oxygen tension, blood pressure and skin temperature. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in heart rate variability (HRV) related to physiological state (diabetics/healthy)
Time Frame: within 4 days of intervention
|
Heart rate variability will be assessed as, e.g., standard deviation in heart rate over a time window of 5 minutes (30 seconds overlap). Changes in mean value and standard deviation of heart rate variability between healthy and diabetic patients will be assessed using statistical tests. |
within 4 days of intervention
|
|
change in local blood perfusion index (BPI) related to physiological state (diabetics/healthy)
Time Frame: within 4 days of intervention
|
Blood perfusion index at the foot will be assessed as peak-peak amplitude (systolic to diastolic) divided by the mean signal value of optically measured blood perfusion. Changes in mean value and standard deviation of local blood perfusion index between healthy and diabetic patients will be assessed using statistical tests. |
within 4 days of intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adverse effects of stimulation
Time Frame: within 4 days of intervention
|
within 4 days of intervention
|
|
|
Change in HRV and local BPI due to distinct stimulation patterns
Time Frame: within 4 days of intervention
|
Two distinct stimulation patterns are tested during intervention. Changes in mean value and standard deviation of HRV/BPI due to these stimulation patterns will be assessed using statistical tests. |
within 4 days of intervention
|
|
Change of local BPI in upper and lower extremities
Time Frame: within 4 days of intervention
|
Local BPI is assessed using optical sensors on the foot and the finger of participants. Changes in mean value of BPI are analyzed using statistical tests. |
within 4 days of intervention
|
|
Changes in blood pressure
Time Frame: within 4 days of intervention
|
Blood pressure is continuously measured using inflatable finger cuffs.
|
within 4 days of intervention
|
|
Changes in respiratory activity
Time Frame: within 4 days of intervention
|
Respiratory activity is monitored using a respiratory belt.
|
within 4 days of intervention
|
|
Changes in oxygen saturation of the toe and wound
Time Frame: within 4 days of intervention
|
within 4 days of intervention
|
|
|
Changes in partial transcutaneous oxygen pressure of the wound region
Time Frame: within 4 days of intervention
|
within 4 days of intervention
|
|
|
Changes in foot skin temperature
Time Frame: within 4 days of intervention
|
within 4 days of intervention
|
|
|
Changes of C reactive protein- and leukocyte-concentration in serum
Time Frame: within 4 days of intervention
|
within 4 days of intervention
|
|
|
Tolerance of stimulation
Time Frame: within 4 days of intervention
|
Tolerance of stimulation is assessed by survey.
|
within 4 days of intervention
|
|
Perception of Stimulation
Time Frame: within 4 days of intervention
|
Perception of stimulation is assessed by survey.
|
within 4 days of intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jozsef C Széles, Dr.med., University Clinic for Surgery, Department of Transplantation, Medical University Vienna
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PS 01/2014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Diabetic Foot Ulcers
-
Bardia AnvarCarbon Life SciencesNot yet recruitingSurgical Wounds | Pressure Ulcers | Chronic Wounds | Trauma Wounds | Arterial Ulcers | Diabetic Foot Ulcers (DFUs) | Burn Wounds | Venous Leg Ulcers (VLUs)
-
StimLabsEnrolling by invitationUlcer | Chronic Ulcers | Diabetic Foot Ulcers (DFU) | DFUUnited States
-
Applied Biologics, LLCSerena GroupRecruitingUlcer | Diabetic Foot Ulcer | Diabetic Foot Ulcers (DFU) | Foot Ulcer ChronicUnited States
-
Tides MedicalSerena GroupCompletedDiabetic Foot Ulcer (DFU) | Lower Extremity Chronic Ulcers in DiabeticsUnited States
-
Biodynamik, IncMayo ClinicNot yet recruitingDiabetic Foot Ulcer | Chronic Ulcers of the Lower LimbUnited States
-
SerenaGroup, Inc.Tides MedicalRecruitingChronic Diabetic Foot UlcersUnited States, Puerto Rico
-
Osiris TherapeuticsTerminatedChronic Diabetic Foot UlcersUnited States
-
3MWithdrawnDiabetic Foot Ulcers | Venous Stasis Ulcers | Pressure Ulcers | Trauma Wounds | Acute and Chronic WoundsUnited States
-
Biotec Pharmacon ASACompletedChronic Diabetic Foot UlcersUnited Kingdom
-
Tissue Regeneration TechnologiesUnknownChronic Diabetic Foot UlcersUnited States
Clinical Trials on PrimeStim
-
Medical University of ViennaVienna University of TechnologyUnknownModulation of Cardiovascular Parameters and Sympathovagal Balance in Healthy SubjectsAustria